The influence of ascorbic acid on active sodium transport in cultured rabbit nonpigmented ciliary epithelium.
OBJECTIVE
Cultured rabbit nonpigmented ciliary epithelium (NPE) transports ascorbic acid (ASC) inward through a sodium-dependent mechanism. This study was conducted to test whether Na-K transport is activated to export the additional sodium, which enters the cell in cotransport with ASC.


METHODS
Studies were conducted using a cell line derived from rabbit NPE. ASC uptake was measured using [14C]ascorbic acid. The ouabain-sensitive potassium (86Rb) uptake rate was measured as an index of active Na-K transport. Cellular sodium was measured by atomic absorption spectrophotometry or SBFI fluorescence.


RESULTS
In the presence of 200 microM ASC, ouabain-sensitive potassium (86Rb) uptake rate increased approximately 70%; lesser concentrations of ASC produced lesser increases. Phloridzin (100 microM) inhibited ASC uptake and inhibited the stimulatory effect of external ASC on 86Rb uptake. Dehydroascorbic acid (DHA) did not increase 86Rb uptake. Neither DHA nor ASC altered the Na,K-ATPase activity measured in isolated membrane material. External ASC appeared to stimulate active sodium transport through a mechanism involving an increase of cytoplasmic sodium. In the presence of 200 microM ASC, cellular sodium increased approximately 26%; studies with cells, sodium loaded by nigericin treatment, suggested that this sodium increase could account for the degree of 86Rb uptake stimulation observed in ASC-treated cells. However, the cellular sodium increase could not be explained simply on the basis of sodium entry through the ASC transporter. An additional sodium-entry pathway seemed to be activated in cells that accumulated ASC. Dimethylamiloride (DMA) abolished both the cellular sodium increase and the 86Rb uptake stimulation caused by ASC. DMA did not prevent ASC uptake.


CONCLUSIONS
ASC significantly stimulated active Na-K transport in cultured NPE. The mechanism appeared to involve activation of a DMA-sensitive sodium entry pathway, which caused cytoplasmic sodium concentration to increase.
Hou
Y
Y
Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Kentucky 40292, USA.
Pierce
W M
WM
Delamere
N A
NA
D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid / Q000378:metabolism / Q000494:pharmacology*; D001693:Biological Transport, Active / Q000187:drug effects; D002460:Cell Line; D002478:Cells, Cultured; D002924:Ciliary Body / Q000187:drug effects / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004848:Epithelium / Q000378:metabolism; D010042:Ouabain / Q000494:pharmacology; D010695:Phlorhizin / Q000494:pharmacology; D010857:Pigment Epithelium of Eye / Q000187:drug effects / Q000378:metabolism*; D011188:Potassium / Q000378:metabolism; D011817:Rabbits; D012414:Rubidium Radioisotopes / Q000378:metabolism; D012964:Sodium / Q000378:metabolism*; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D013054:Spectrophotometry, Atomic
D004791:Enzyme Inhibitors; D012414:Rubidium Radioisotopes; C039465:5-dimethylamiloride; D010042:Ouabain; D000584:Amiloride; D012964:Sodium; D010695:Phlorhizin; D000254:Sodium-Potassium-Exchanging ATPase; D001205:Ascorbic Acid; D011188:Potassium